摘要
英国建立了相对完善合理的药品定价制度机制,并随其国情变化而不断更新。其品牌药品定价和准入自愿计划、高度专业化技术评估以及社区药房合同框架等新政的推行在合理控制卫生支出、保证患者用药、强化创新活力这些矛盾目标之间取得了较好的平衡。本文对英国的药品定价政策及最新进展进行研究,借鉴其有益思路与方法,在中国药价形成领域的管控方式、参与机制、评估评价方法以及药品补偿机制等4个方面提出启示和政策建议。
The United Kingdom has set up a sound and reasonable drug pricing system,which is constantly updated with changes of its national conditions.Its Voluntary Scheme for Branded Medicines Pricing and Access,Highly Specialised Technology and The Community Pharmacy Contractual Framework and other new policies have achieved good results in balance of the contradictory goals of reasonable control of health expenditure,ensuring patients’medication and strengthening innovation vitality.This paper studies the drug pricing policy and the latest progress in the United Kingdom,and draws on its useful ideas and methods to put forward policy suggestions for the optimization of China’s drug market in four aspects:control mode,participation mechanism,evaluation method and drug compensation mechanism.
作者
吕兰婷
刘文凤
LYU Lanting;LIU Wenfeng(Renmin University of China,School of Public Administration and Policy,Beijing 100872,China;Renmin University of China,Health Technology Assessment and Policy Evaluation Group,Beijing 100872,China)
出处
《中国现代应用药学》
CAS
CSCD
北大核心
2021年第3期345-349,共5页
Chinese Journal of Modern Applied Pharmacy
基金
中国人民大学科学研究基金(中央高校基本科研业务费专项资金资助)项目成果(20XNA004)。
关键词
药品定价
药价管制
英国
drug pricing
pharmaceutical price control
the United Kingdom
